MedPath

To compare the effectiveness of a local anaesthetic(Ropivacaine) and the same drug with an adjuvant (Dexmedetomidine) as an anaesthesia technique given around nerve bundle above the collar bone for arm surgeries using ultrasound guidance

Not Applicable
Conditions
Health Condition 1: null- ASA 1 and 2 male and female between 18 to 70 years of age for upper limb surgeries below mid humerus.Health Condition 2: S50-S59- Injuries to the elbow and forearmHealth Condition 3: S60-S69- Injuries to the wrist, hand and fingers
Registration Number
CTRI/2018/12/016701
Lead Sponsor
Department of Anaesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA physical status 1 and 2, of either gender between 18 and 70 years of age for upper limb surgeries below mid humerus

Exclusion Criteria

morbid obesity, coagulopathy, uncontrolled diabetes mellitus, peripheral vascular disease, neurological disease, known allergy to local anaesthetics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dexmedetomidine added to Ropivacaine prolongs the duration of analgesia, in hastening and prolonging sensory and motor block when compared to Ropivacaine alone in supraclavicular brachial plexus block for upper limb surgeriesTimepoint: Hemodynamic parameters,sensory and motor block, analgesia are assessed at 5, 10, 15, 20, 25, and 30 min and thereafter every 15 min for 1 hour till the block effect has resolved
Secondary Outcome Measures
NameTimeMethod
Dexmedetomidine added to Ropivacaine is safer when compared to Ropivacaine alone in supraclavicular brachialplexus block for upper limb surgeriesTimepoint: Adverse effects are assessed at 5, 10, 15, 20, 25, and 30 min and thereafter every 15 min for 1 hour till the block effect has resolved
© Copyright 2025. All Rights Reserved by MedPath